USD 28.22
(-2.49%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 278.64 Million USD | -11.6% |
2022 | 315.18 Million USD | 22.92% |
2021 | 256.42 Million USD | 63.05% |
2020 | 157.26 Million USD | 2854.52% |
2019 | 5.32 Million USD | -14.28% |
2018 | 6.21 Million USD | 42.24% |
2017 | 4.36 Million USD | 0.0% |
2016 | - USD | 0.0% |
2015 | - USD | 0.0% |
2014 | - USD | 0.0% |
2013 | - USD | 0.0% |
2012 | - USD | 0.0% |
2011 | - USD | 0.0% |
2010 | - USD | 0.0% |
2009 | - USD | 0.0% |
2008 | - USD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2023 Q2 | 298.97 Million USD | 4.27% |
2023 Q1 | 286.73 Million USD | -16.94% |
2023 Q4 | 281.06 Million USD | 0.87% |
2023 Q3 | 278.64 Million USD | -6.8% |
2023 FY | 278.64 Million USD | -11.6% |
2022 Q1 | 13.29 Million USD | 16.91% |
2022 Q3 | 315.18 Million USD | 2423.33% |
2022 Q4 | 345.19 Million USD | 9.52% |
2022 FY | 315.18 Million USD | 22.92% |
2022 Q2 | 12.49 Million USD | -6.05% |
2021 Q2 | 11.31 Million USD | 19.94% |
2021 Q4 | 11.37 Million USD | -1.99% |
2021 Q3 | 11.6 Million USD | 2.6% |
2021 Q1 | 9.43 Million USD | 2.79% |
2021 FY | 256.42 Million USD | 63.05% |
2020 FY | 157.26 Million USD | 2854.52% |
2020 Q2 | 5.9 Million USD | -1.6% |
2020 Q3 | 7.5 Million USD | 27.09% |
2020 Q4 | 9.17 Million USD | 22.22% |
2020 Q1 | 6 Million USD | 12.76% |
2019 Q3 | 4.91 Million USD | -4.77% |
2019 Q2 | 5.15 Million USD | -8.66% |
2019 Q4 | 5.32 Million USD | 8.39% |
2019 Q1 | 5.64 Million USD | -9.08% |
2019 FY | 5.32 Million USD | -14.28% |
2018 Q3 | 5.54 Million USD | -10.84% |
2018 FY | 6.21 Million USD | 42.24% |
2018 Q1 | 5.43 Million USD | 24.55% |
2018 Q2 | 6.22 Million USD | 14.38% |
2018 Q4 | 6.21 Million USD | 11.97% |
2017 Q2 | 1.63 Million USD | 0.0% |
2017 Q1 | - USD | 0.0% |
2017 FY | 4.36 Million USD | 0.0% |
2017 Q4 | 4.36 Million USD | 42.03% |
2017 Q3 | 3.07 Million USD | 87.9% |
2016 FY | - USD | 0.0% |
2016 Q1 | - USD | 0.0% |
2016 Q4 | - USD | 0.0% |
2016 Q3 | - USD | 0.0% |
2016 Q2 | - USD | 0.0% |
2015 Q4 | - USD | 0.0% |
2015 Q3 | - USD | 0.0% |
2015 FY | - USD | 0.0% |
2015 Q1 | - USD | 0.0% |
2015 Q2 | - USD | 0.0% |
2014 Q3 | - USD | 0.0% |
2014 Q2 | - USD | 0.0% |
2014 Q1 | - USD | 0.0% |
2014 FY | - USD | 0.0% |
2014 Q4 | - USD | 0.0% |
2013 Q1 | - USD | 0.0% |
2013 Q3 | - USD | 0.0% |
2013 Q4 | - USD | 0.0% |
2013 FY | - USD | 0.0% |
2013 Q2 | - USD | 0.0% |
2012 Q2 | - USD | 0.0% |
2012 Q3 | - USD | 0.0% |
2012 Q4 | - USD | 0.0% |
2012 FY | - USD | 0.0% |
2012 Q1 | - USD | 0.0% |
2011 Q4 | - USD | 0.0% |
2011 Q3 | - USD | 0.0% |
2011 Q2 | - USD | 0.0% |
2011 Q1 | - USD | 0.0% |
2011 FY | - USD | 0.0% |
2010 Q2 | - USD | 0.0% |
2010 FY | - USD | 0.0% |
2010 Q4 | - USD | 0.0% |
2010 Q3 | - USD | 0.0% |
2010 Q1 | - USD | 0.0% |
2009 Q3 | - USD | 0.0% |
2009 Q2 | - USD | 0.0% |
2009 Q1 | - USD | 0.0% |
2009 FY | - USD | 0.0% |
2009 Q4 | - USD | 0.0% |
2008 Q4 | - USD | 0.0% |
2008 Q2 | - USD | 0.0% |
2008 Q1 | - USD | 0.0% |
2008 FY | - USD | 0.0% |
2008 Q3 | - USD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Cosmos Health Inc. | 4.78 Million USD | -5718.31% |
Safety Shot Inc | 1.86 Million USD | -14803.455% |
Bright Green Corporation | - USD | -Infinity% |
Embecta Corp. | 152.1 Million USD | -83.197% |
ANI Pharmaceuticals, Inc. | 111.19 Million USD | -150.586% |
Aquestive Therapeutics, Inc. | 6.76 Million USD | -4016.443% |
Collegium Pharmaceutical, Inc. | 32.33 Million USD | -761.815% |
Dynavax Technologies Corporation | 53.29 Million USD | -422.879% |
Esperion Therapeutics, Inc. | 65.62 Million USD | -324.61% |
Intra-Cellular Therapies, Inc. | 11.64 Million USD | -2292.393% |
Pacira BioSciences, Inc. | 104.35 Million USD | -167.019% |
PainReform Ltd. | - USD | -Infinity% |
Sunshine Biopharma, Inc. | 5.73 Million USD | -4758.83% |
Sunshine Biopharma, Inc. | 5.73 Million USD | -4758.83% |
SCYNEXIS, Inc. | - USD | -Infinity% |
China SXT Pharmaceuticals, Inc. | 809.75 Thousand USD | -34310.57% |
Journey Medical Corporation | 10.2 Million USD | -2630.178% |
Alpha Teknova, Inc. | 11.59 Million USD | -2303.329% |
Procaps Group, S.A. | 96.83 Million USD | -187.755% |
Theratechnologies Inc. | 6.06 Million USD | -4493.505% |
Harrow Health, Inc. | 10.86 Million USD | -2464.112% |
Sonoma Pharmaceuticals, Inc. | 2.71 Million USD | -10147.959% |
Biofrontera Inc. | 10.9 Million USD | -2454.474% |
DURECT Corporation | 2.21 Million USD | -12457.098% |
Supernus Pharmaceuticals, Inc. | 77.4 Million USD | -259.965% |
Cronos Group Inc. | 30.33 Million USD | -818.429% |
OptiNose, Inc. | 8.05 Million USD | -3360.532% |
Ironwood Pharmaceuticals, Inc. | 1.00 USD | -27864199900.0% |
Kala Pharmaceuticals, Inc. | - USD | -Infinity% |
RedHill Biopharma Ltd. | 5.69 Million USD | -4789.286% |
Organogenesis Holdings Inc. | 28.25 Million USD | -886.239% |
Guardion Health Sciences, Inc. | 2.67 Million USD | -10308.306% |
Cumberland Pharmaceuticals Inc. | 4.6 Million USD | -5945.132% |
Universe Pharmaceuticals INC | 3.34 Million USD | -8234.425% |
ProPhase Labs, Inc. | 3.84 Million USD | -7154.413% |
Phibro Animal Health Corporation | 265.91 Million USD | -4.788% |
Procaps Group S.A. | 96.83 Million USD | -187.755% |
Alvotech | 74.43 Million USD | -274.353% |
TherapeuticsMD, Inc. | - USD | -Infinity% |
Viatris Inc. | 3.46 Billion USD | 91.969% |
Rockwell Medical, Inc. | 5.87 Million USD | -4646.074% |
Aytu BioPharma, Inc. | 12.63 Million USD | -2105.668% |
SIGA Technologies, Inc. | 64.21 Million USD | -333.898% |
Tilray Brands, Inc. | 252.08 Million USD | -10.534% |
Lifecore Biomedical, Inc. | 39.97 Million USD | -596.971% |
Shineco, Inc. | 1.58 Million USD | -17440.926% |
PetIQ, Inc. | 159.3 Million USD | -74.907% |
Regencell Bioscience Holdings Limited | -152.77 Thousand USD | 182483.589% |
Incannex Healthcare Limited | -10.01 Million USD | 2882.247% |
Neurocrine Biosciences, Inc. | 38.3 Million USD | -627.525% |
Alimera Sciences, Inc. | 1.87 Million USD | -14729.271% |
Silver Spike Investment Corp. | - USD | -Infinity% |
Assertio Holdings, Inc. | 37.68 Million USD | -639.378% |
Shuttle Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
Petros Pharmaceuticals, Inc. | 1.61 Million USD | -17202.754% |
Clever Leaves Holdings Inc. | 4.48 Million USD | -6115.525% |
Cyclo Therapeutics, Inc. | 254.35 Thousand USD | -109449.758% |
Avadel Pharmaceuticals plc | 10.38 Million USD | -2584.412% |
Hempacco Co., Inc. | 2.54 Million USD | -10858.819% |
Talphera, Inc. | - USD | -Infinity% |
Alvotech | 74.43 Million USD | -274.353% |
Eagle Pharmaceuticals, Inc. | 47.79 Million USD | -483.006% |
Lantheus Holdings, Inc. | 64.02 Million USD | -335.181% |
Currenc Group, Inc. | 732.91 Thousand USD | -37918.532% |
Kamada Ltd. | 87.74 Million USD | -217.553% |
Indivior PLC | 141.79 Million USD | -96.504% |
Evoke Pharma, Inc. | 481.84 Thousand USD | -57728.74% |
Flora Growth Corp. | 8.5 Million USD | -3175.059% |
Cyclo Therapeutics, Inc. | 254.35 Thousand USD | -109449.758% |
Evolus, Inc. | 10.99 Million USD | -2433.57% |
HUTCHMED (China) Limited | 50.25 Million USD | -454.423% |
Amphastar Pharmaceuticals, Inc. | 105.83 Million USD | -163.285% |
Akanda Corp. | 1.28 Million USD | -21552.288% |